vs
HORIZON BANCORP INC（HBNC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是HORIZON BANCORP INC的1.1倍（$69.8M vs $63.5M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 42.4%，领先341.6%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 19.5%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 9.2%）
第一地平线集团（原第一田纳西银行）是一家金融服务企业，1864年成立，总部位于美国田纳西州孟菲斯。集团通过旗下银行子公司第一地平线银行，在美国东南部12个州开展金融业务，是该区域第四大区域性银行。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
HBNC vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$63.5M
营收增速更快
RIGL
高出1.7%
19.5%
净利率更高
RIGL
高出341.6%
42.4%
两年增速更快
RIGL
近两年复合增速
9.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $63.5M | $69.8M |
| 净利润 | $26.9M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 51.5% | 33.2% |
| 净利率 | 42.4% | 384.0% |
| 营收同比 | 19.5% | 21.2% |
| 净利润同比 | 347.4% | 1769.2% |
| 每股收益（稀释后） | $0.44 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HBNCRIGL
| Q4 25 | $63.5M | $69.8M | ||
| Q3 25 | $58.4M | $69.5M | ||
| Q2 25 | $66.3M | $101.7M | ||
| Q1 25 | $68.8M | $53.3M | ||
| Q4 24 | $53.1M | $57.6M | ||
| Q3 24 | $58.4M | $55.3M | ||
| Q2 24 | $55.8M | $36.8M | ||
| Q1 24 | $53.2M | $29.5M |
净利润HBNCRIGL
| Q4 25 | $26.9M | $268.1M | ||
| Q3 25 | $-222.0M | $27.9M | ||
| Q2 25 | $20.6M | $59.6M | ||
| Q1 25 | $23.9M | $11.4M | ||
| Q4 24 | $-10.9M | $14.3M | ||
| Q3 24 | $18.2M | $12.4M | ||
| Q2 24 | $14.1M | $-1.0M | ||
| Q1 24 | $14.0M | $-8.2M |
毛利率HBNCRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率HBNCRIGL
| Q4 25 | 51.5% | 33.2% | ||
| Q3 25 | -490.4% | 40.9% | ||
| Q2 25 | 36.8% | 60.1% | ||
| Q1 25 | 40.8% | 23.9% | ||
| Q4 24 | -41.3% | 28.9% | ||
| Q3 24 | 31.0% | 25.4% | ||
| Q2 24 | 28.5% | 1.2% | ||
| Q1 24 | 28.8% | -23.6% |
净利率HBNCRIGL
| Q4 25 | 42.4% | 384.0% | ||
| Q3 25 | -380.2% | 40.2% | ||
| Q2 25 | 31.1% | 58.6% | ||
| Q1 25 | 34.8% | 21.5% | ||
| Q4 24 | -20.5% | 24.9% | ||
| Q3 24 | 31.1% | 22.5% | ||
| Q2 24 | 25.4% | -2.8% | ||
| Q1 24 | 26.3% | -27.9% |
每股收益（稀释后）HBNCRIGL
| Q4 25 | $0.44 | $14.11 | ||
| Q3 25 | $-4.69 | $1.46 | ||
| Q2 25 | $0.47 | $3.28 | ||
| Q1 25 | $0.54 | $0.63 | ||
| Q4 24 | $-0.25 | $0.82 | ||
| Q3 24 | $0.41 | $0.70 | ||
| Q2 24 | $0.32 | $-0.06 | ||
| Q1 24 | $0.32 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $139.5M | $155.0M |
| 总债务越低越好 | $248.6M | $52.5M |
| 股东权益账面价值 | $688.3M | $391.5M |
| 总资产 | $6.4B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.36× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资HBNCRIGL
| Q4 25 | $139.5M | $155.0M | ||
| Q3 25 | $458.3M | $137.1M | ||
| Q2 25 | $137.9M | $108.4M | ||
| Q1 25 | $169.7M | $77.1M | ||
| Q4 24 | $293.4M | $77.3M | ||
| Q3 24 | $234.8M | $61.1M | ||
| Q2 24 | $146.1M | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务HBNCRIGL
| Q4 25 | $248.6M | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | $1.2B | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益HBNCRIGL
| Q4 25 | $688.3M | $391.5M | ||
| Q3 25 | $660.8M | $117.6M | ||
| Q2 25 | $790.9M | $81.9M | ||
| Q1 25 | $776.1M | $18.6M | ||
| Q4 24 | $763.6M | $3.3M | ||
| Q3 24 | $754.8M | $-14.6M | ||
| Q2 24 | $726.7M | $-29.9M | ||
| Q1 24 | $721.3M | $-31.7M |
总资产HBNCRIGL
| Q4 25 | $6.4B | $513.6M | ||
| Q3 25 | $6.7B | $242.5M | ||
| Q2 25 | $7.7B | $206.7M | ||
| Q1 25 | $7.6B | $176.0M | ||
| Q4 24 | $7.8B | $164.0M | ||
| Q3 24 | $7.9B | $139.4M | ||
| Q2 24 | $7.9B | $128.4M | ||
| Q1 24 | $7.9B | $126.5M |
负债/权益比HBNCRIGL
| Q4 25 | 0.36× | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | 1.61× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $79.2M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $74.3M | — |
| 自由现金流率自由现金流/营收 | 117.0% | — |
| 资本支出强度资本支出/营收 | 7.8% | — |
| 现金转化率经营现金流/净利润 | 2.94× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $115.9M | — |
8季度趋势，按日历期对齐
经营现金流HBNCRIGL
| Q4 25 | $79.2M | $22.0M | ||
| Q3 25 | $10.9M | $24.0M | ||
| Q2 25 | $19.5M | $30.5M | ||
| Q1 25 | $15.2M | $-893.0K | ||
| Q4 24 | $6.4M | $14.5M | ||
| Q3 24 | $32.3M | $21.7M | ||
| Q2 24 | $15.9M | $302.0K | ||
| Q1 24 | $6.5M | $-5.0M |
自由现金流HBNCRIGL
| Q4 25 | $74.3M | — | ||
| Q3 25 | $9.4M | — | ||
| Q2 25 | $18.1M | — | ||
| Q1 25 | $14.1M | — | ||
| Q4 24 | $1.3M | — | ||
| Q3 24 | $31.0M | — | ||
| Q2 24 | $15.1M | — | ||
| Q1 24 | $5.4M | — |
自由现金流率HBNCRIGL
| Q4 25 | 117.0% | — | ||
| Q3 25 | 16.1% | — | ||
| Q2 25 | 27.3% | — | ||
| Q1 25 | 20.5% | — | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 53.1% | — | ||
| Q2 24 | 27.1% | — | ||
| Q1 24 | 10.1% | — |
资本支出强度HBNCRIGL
| Q4 25 | 7.8% | — | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 1.6% | — | ||
| Q4 24 | 9.6% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 2.2% | — |
现金转化率HBNCRIGL
| Q4 25 | 2.94× | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | 0.94× | 0.51× | ||
| Q1 25 | 0.64× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 1.78× | 1.75× | ||
| Q2 24 | 1.13× | — | ||
| Q1 24 | 0.47× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
